Press releases

07 March 2018

Organ Care System: MHH physicians treat diseased lung outside the body

The growing resistance of pathogens to antibiotics means that, in an increasing number of cases, doctors are out of alternative treatment options for severe pneumonia. Medics at Hannover Medical School (MHH) have, for the first... [more]

18 December 2017

Gene therapy for rare blood condition

Scientists at Hannover Medical School (MHH) have achieved a first: they have developed a successful cell and gene therapy for a genetic infectious disease. It appears to be a promising treatment for a rare and life-threatening... [more]

06 December 2017

How are artificial lungs implanted?

For people with certain serious lung conditions, a lung transplant is the only curative treatment option.  However, only a small proportion of patients can receive this treatment, as there are fewer and fewer organ donors... [more]

09 November 2017

Reducing scar size after heart attack

Scientists at Hannover Medical School (MHH) have discovered a previously unknown growth factor that improves cardiac muscle healing after a heart attack, so that even a major infarction results in only a small scar. They... [more]

06 November 2017

Innovation is the basis for new fibrosis treatment

It is often the case that one only realizes how important something is when it stops working. Researchers at Hannover Medical School (MHH) have capitalized on this fact: using a new method, they succeeded in specifically... [more]

29 September 2017

Cluster of Excellence REBIRTH took the first hurdle within the German Strategy of Excellence

The Cluster of Excellence REBIRTH took the first hurdle within the Excellence Strategy of the federal government and states: The Cluster is invited to submit the full proposal for the new concept REBIRTHT4S (From Regenerative... [more]

11 May 2017

Spinoff company receives a boost worth millions

“We use what are known as non-coding ribonucleic acids (RNAs) to diagnose and treat heart conditions such as cardiac insufficiency,“ says Professor Thomas Thum, founder of a Hannover Medical School (MHH) spinoff company called... [more]

02 May 2017

Post-heart-attack cellular therapy: expectations unfulfilled

Following a major heart attack, patients’ risk of developing a persistent weakening of the heart muscle (i.e. cardiac insufficiency) remains just as high as it was – despite cellular therapy. Based on a trial entitled BOOST... [more]

07 April 2017

REBIRTH sets learning in motion

Children and adolescents are exercising less and less. To boost awareness of preventive action among parents and in schools, Hannover Medical School (MHH) is launching a two-year motion study called ‘REBIRTH active school’ in... [more]

30 March 2017

“’Ideas Expo’ is often the initial spark that results in a decision to study science or technology”

The REBIRTH Cluster of Excellence will be present, with an exhibit covering some 1,000 square metres, at the 2017 IdeenExpo event held on 10–18 June. Hannover Medical School (MHH) and the University of Hannover will be... [more]

08 March 2017

Alternatives to animal experimentation in research

Lower Saxony’s Ministry of Science and Culture has launched a new research alliance, which it is funding to the tune of 4.5 million euros. Called R2N, its aim is to replace and reduce the use of animals as part of the way forward... [more]

07 March 2017

Technion: REBIRTH-Wissenschaftlerin erhält Forschungspreis

Professor Denise Hilfiker-Kleiner of Hannover Medical School’s (MHH) Department of Cardiology and Angiology, who is dean of research at MHH and heads up the REBIRTH unit on Endogenous Regeneration Mechanisms of the Heart, had the... [more]

17 January 2017

Arteriosclerosis: prevailing wisdom called into question

A new theory from Professor Haverich: it is not blood lipids but impaired blood supply to the arterial wall that leads to deposits on inner vascular walls and gives rise to arterial calcification (i.e. arteriosclerosis).... [more]

06 January 2017

GATA4 offers recovery for the heart

Why does the heart regeneration functions only shortly after birth? The team headed by Professor Dr. Jörg Heineke from the MHH-Department of Cardiology and Angiology of the REBIRTH Unit Myocardial Cellular Crosstalk and Gene... [more]

16 December 2016

CRISPR-Cas9: REBIRTH researchers optimise gene correction tool

Researchers at Hannover Medical School (MHH) have developed a refined method to genetically correct patient derived induced pluripotent stem cells (iPS cells) using the CRISPR-Cas9 tool. For this purpose the team around Professor... [more]

<< First < Previous 1-15 16-30 31-45 46-60 61-75 76-90 91-105 Next > Last >>